인쇄하기
취소

Qurient acquires patent of Quinolinyloxyphenylsulfonamides related to cancer treatment

Published: 2017-07-14 10:44:00
Updated: 2017-07-14 10:44:00

Qurient gave an official notice on the 12th that it acquired a patent of Quinolinyloxyphenylsulfonamides related to cancer treatment.

According to the company, the patent is about the core chemical structure of the anticancer immunity/resistance study and the use of its compound.(patentee: Max Planck Institutes in Germany)

Qurient said “The patent is a patent registered in Europe(Patent no. E...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.